Medtronic (NYSE:MDT) today launched its newest drug-eluting coronary stent, Onyx Frontier. The Fridley, Minnesota-based company designed the Onyx Frontier drug-eluting stent (DES) to build upon its Resolute Onyx DES. It uses the same stent platform as the Resolute Onyx and has an enhanced delivery system to increase acute performance in … [Read more...] about Medtronic launches Onyx Frontier drug-eluting stent
Catheters
Imagin Medical acquires Trod Medical’s enCage Coil precision ablation system
Imagin Medical this week announced it has acquired Trod Medical's enCage Coil precision ablation system. The company will acquire the enCage Coil for $2.5 million, which will be paid over time once certain developmental milestones are met. There will be an initial payment on the closing of $350,000 and $150,000 of Imagin shares. Of the initial … [Read more...] about Imagin Medical acquires Trod Medical’s enCage Coil precision ablation system
BD initiates first-in-human trial of sirolimus drug-coated balloon
BD today announced it started enrollment in the first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). The Prevision trial is a prospective, multi-center, single-arm, non-randomized study that will evaluate the safety of BD's DCB in the treatment of peripheral arterial disease (PAD) in the femoropopliteal arteries. The company … [Read more...] about BD initiates first-in-human trial of sirolimus drug-coated balloon
The 24 best medical device innovations of 2022
The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products … [Read more...] about The 24 best medical device innovations of 2022
Boston Scientific acquires Obsidio and its gel embolic material
Boston Scientific (NYSE:BSX) today announced the acquisition of Obsidio and its blood vessel embolization material technology. The financial details of the deal were not disclosed. Obsidio develops gel embolic material (GEM) technology that is used for the embolization of blood vessels in the peripheral vasculature. It is a semi-solid, gel-link … [Read more...] about Boston Scientific acquires Obsidio and its gel embolic material
MedAlliance sirolimus-eluting balloon wins second FDA IDE
MedAlliance this week announced its Selution SLR sirolimus-eluting balloon received conditional FDA investigational device exemption (IDE) approval to begin a clinical trial for occlusive disease of the superficial femoral artery (SFA). The second IDE approval comes a few months after the Geneva, Switzerland-based company won IDE approval for … [Read more...] about MedAlliance sirolimus-eluting balloon wins second FDA IDE
FDA clears Glaukos’ iStent Infinite
Glaukos this week announced it received FDA 510(k) clearance for its iStent Infinite trabecular micro-bypass system. The FDA clearance indication is for use in a standalone procedure to reduce elevated intraocular pressure (IOP) in patients who have primary open-angle glaucoma. San Clemente, California-based Glaukos designed iStent Infinite … [Read more...] about FDA clears Glaukos’ iStent Infinite
Abbott launches TactiFlex SE radiofrequency ablation catheter in Japan
Abbott this week announced it has launched its TactiFlex SE irrigation catheter in Japan. TactiFlex SE is a radiofrequency (RF) ablation catheter with a slit tip electrode with contact force technology. The tip of the catheter is flexible and conforms to the shape of the heart's wall for unique patient anatomies. The slit structure on the … [Read more...] about Abbott launches TactiFlex SE radiofrequency ablation catheter in Japan
Teleflex’s central venous access catheters awarded Vizient supply contract
Teleflex today announced it was awarded a contract for the supply of central venous access devices from Vizient, effective immediately. The agreement allows Vizient members to take advantage of special pricing for Teleflex's line of central venous access catheters (CVCs). The group purchasing agreement includes Teleflex's Arrowg+ard Blue Plus … [Read more...] about Teleflex’s central venous access catheters awarded Vizient supply contract
Medtronic’s Covidien Palindrome and Mahurkar hemodialysis catheter recall is Class I
Medtronic's subsidiary Covidien issued a Class I recall of more than 1 million Palindrome and Mahurkar hemodialysis catheters. Covidien issued the recall due to a catheter hub defect that will connect both extension catheters. The defect could leak within the hub of a chronic dialysis catheter, which can lead to mixing of the arterial and venous … [Read more...] about Medtronic’s Covidien Palindrome and Mahurkar hemodialysis catheter recall is Class I